Australian drugs regulator cancels registration of COX 2 inhibitor.
Burton
Bob
B
D001315:Australia; D052246:Cyclooxygenase 2 Inhibitors / Q000009:adverse effects / Q000600:supply & distribution*; D004008:Diclofenac / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000600:supply & distribution; D017277:Drug Approval; D006801:Humans; D010003:Osteoarthritis / Q000188:drug therapy*
D052246:Cyclooxygenase 2 Inhibitors; D004008:Diclofenac; C473384:lumiracoxib